Omeros OMER
NASDAQ OMER
$17.30 -0.25 (-1.42%)
At close: Nov 10, 2026 · 4:00 PM EST

Omeros (OMER) Return on Equity [ROE] (2010 - 2023)

Updated

Omeros' Return on Equity [ROE] came in at -388.17% for FY2023, down 474.81 percentage points from 86.63% in FY2022.

Analysis

Omeros (OMER) Return on Equity [ROE] (2010 - 2023) Analysis & Trends

Going back to FY2010, Omeros' Return on Equity [ROE] data covers 4 years.

  • The FY2023 figure represents the lowest annual Return on Equity [ROE] since FY2011.
  • Per Business Quant, earlier years put Return on Equity [ROE] at 86.63% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Omeros 234.42 Mn -206.99 Mn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 609.58%
Jun 30, 2023 106.78%
Mar 31, 2023 66.46%
Dec 31, 2022 240.88%
Mar 31, 2022 2,082.35%
Dec 31, 2017 -1,672.07%
Jun 30, 2015 -499.62%
Sep 30, 2011 -385.94%
Jun 30, 2011 -230.28%
Mar 31, 2011 -177.31%
Dec 31, 2010 -140.93%
Sep 30, 2010 -117.32%
API Access

Omeros Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY